Antipsychotic drug therapy and sexual dysfunction in men
- 1 May 1982
- journal article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 139 (5) , 633-637
- https://doi.org/10.1176/ajp.139.5.633
Abstract
The authors review the literature on male sexual dysfunction associated with antipsychotic drug treatment. Erectile and ejaculatory disturbances have been most frequently reported. Changes in libido have also been reported, but the effects of these drugs on sexual drive have apparently not been systematically studied. Fortunately, most types of sexual dysfunction associated with antipsychotic drugs appear to be medically benign and reversible with drug discontinuation. An exception is priapism, which necessitates prompt urological consultation and may require surgical intervention.Keywords
This publication has 41 references indexed in Scilit:
- Neuroendocrine effects of chronic neuroleptic therapy in male psychiatric patientsPsychoneuroendocrinology, 1978
- Fluphenazine therapy in groupsComprehensive Psychiatry, 1977
- Association of Priapism in Phenothiazine TherapyJournal of Urology, 1976
- Drugs and sexual behavior in manLife Sciences, 1975
- Priapism: A Review of 46 CasesJournal of Urology, 1974
- Sexual dysfunction associated with Mesoridazine Besylate (Serentil)Psychopharmacology, 1972
- Aspermia: A Survey of 49 CasesFertility and Sterility, 1968
- The Infertile Male: A Diagnostic ApproachFertility and Sterility, 1966
- Ejaculatory SterilityFertility and Sterility, 1965
- Sexual Dysfunction Associated With Thioridazine HydrochlorideJAMA, 1964